Whether pulse pressure amplification (PPA) relates to established markers of cardiovascular risk is unknown. The purpose of this study was to investigate the relationship between PPA and cardiovascular risk factors and cardiovascular risk in a population-based sample of 40-to 80-year old men.
Pulse pressure increases progressively from the central arteries to the peripheral arteries, mainly because of a rise in systolic pressure. This so-called pulse pressure amplification (PPA) is a well-established hemodynamic phenomenon in cardiovascular physiology. 1 PPA has been attributed to the traveling of the pressure wave from central to peripheral arteries that become less distensible. At each distinct site of the arterial tree, the pressure wave form is the sum of the forward traveling wave and the backward traveling wave, caused by reflections at peripheral sites. In young adults with a highly compliant aorta, PPA is the result of progressive stiffening of arteries with increasing distance from the heart. As a consequence of PPA, systolic or pulse pressure measured at the brachial artery may deviate from the actual central aortic blood pressure level, which is lower. This is important, since it is the aortic pressure that determines the workload of the heart. With aging, the central muscular arteries become stiffer more rapidly than the brachial arteries, leading to change in amplitude and contour of the pressure wave. As a consequence, central pulse pressure increases more than brachial pulse pressure and the physiological PPA is attenuated. 1 This loss of the normal arterial stiffness gradient and PPA, and increase in arterial pulsatile pressure may lead to the transmission of potentially harmful forward pressure waves into the microcirculation of vasodilated organs such as the brain, kidney, and heart. 2 Apart from aging, a number of well-known cardiovascular risk factors, including diabetes, hyperlipidemia, smoking, and hypertension enhance central arterial stiffness, eventually leading to a greater risk of coronary artery disease and stroke. Previous studies have demonstrated that the degree of PPA is, indeed, inversely related to a number of cardiovascular risk factors; posture, 3 smoking, 4 exercise, 5 and hypercholesterolemia. 6 Premature arterial stiffening has also been associated with hypertension and diabetes mellitus. 7 Because of these associations, individuals with high PPA are likely to be at lower cardiovascular risk than subjects with low PPA. Yet, relationships between PPA and markers of vascular risk, such as aortic stiffness and carotid intima-media thickness (CIMT) are lacking. We examined the relation of PPA with markers of vascular risk factors and Framingham risk estimates using data from a population-based sample of 40 to 80-year-old men.
methoDS
Study design and population. We conducted a cross-sectional, single-center study in 400 male subjects aged between 40 and articles Pulse Pressure Amplification and Cardiovascular Disease 80 years. The subjects and methods of recruitment of this study have been described elsewhere. [8] [9] [10] The subjects were recruited by asking women participating in other studies conducted by the department by letter whether they possibly knew interested men between ages 40 and 80. Invitation letters were sent to 770 participating women. Although it was not possible to assess the participation rate for this group, 240 men volunteered for participation. Next, the names and addresses of randomly selected men aged 40-80 were drawn from the municipal register of Utrecht, a large-sized town in the central part of the Netherlands. A total of 1,230 invitation letters were sent to men living in Utrecht through a selection from the municipal register. From this group, 390 men volunteered for participation (participation rate of 31.7%). From the 630 volunteers, we excluded those who did not live independently and subjects who were not physically or mentally able to visit the study center independently (n = 16). No additional healthrelated eligibility criteria were used. Of the remaining 614 men, 400 men were randomly selected to participate. To yield equal numbers in each age decade from ages 40 to 80, we sampled 100 men in each decade of age. All participants gave written informed consent before enrollment in the study, and the institutional review board of the University Medical Center Utrecht approved the study. Data collection took place between March 2001 and April 2002.
Measurements of demographic and behavioral variables.
Height, weight, and waist and hip circumference were measured with the participant in standing position wearing indoor clothes and no shoes. Physical activity was assessed using a questionnaire that was validated in an elderly population. 11 Low scores represent low physical activity. Smoking was estimated from self-report and categorized in current, former, and never smokers, as well as in pack-years. Alcohol intake was estimated using a validated food frequency questionnaire. 12, 13 Prevalence of disease. A medical doctor obtained information on the prevalence of disease and the use of medication from a specified medical history. Diseases were classified using the ICD-10 classification. Hypertension was defined as systolic blood pressure (SBP) ≥140 mm Hg and/or diastolic blood pressure (DBP) ≥90 mm Hg and/or the use of antihypertensive medication. Diabetes mellitus was defined as treatment with insulin or oral glucose-lowering agents and/or fasting plasma venous glucose >6.9 mmol/l. Hyperlipidemia was defined as serum total cholesterol >6.5 mmol/l and/or treatment with lipid-lowering medication. Presence of cardiovascular disease was defined as a history of coronary heart disease, peripheral artery disease or cerebrovascular disease.
Laboratory measurements. Venous blood samples were collected. Platelet-free serum was obtained by centrifugation and was immediately stored at −20 °C until analysis. Fasting total cholesterol, high-density lipoprotein cholesterol and triglycerides were measured using an automatic enzymatic procedure (Synchron LX Systems; Beckman Coulter, Mijdrecht, The Netherlands). The low-density lipoprotein cholesterol concentration was estimated using the Friedewald formula. 14 The fasting blood glucose was determined using a reagent-strip glucose oxidase method. Glucose levels were assessed using a GlucoTouch reflectometer (LifeScan, Benelux, Beerse, Belgium). Venous whole blood was immediately applied to the test strip.
Cardiovascular assessments. Blood pressure was measured in the morning after 10 min rest, twice on the right upper arm (sitting position) with a semiautomated device (Dinamap 8100; Critikon, Tampa, Finland). The average of the two measurements of systolic and diastolic blood pressure was used for analysis. Brachial PP was calculated as SBP − DBP, and mean arterial pressure (MAP) was calculated as (2 × DBP + SBP)/3.
Central vascular measurements were performed using the SphygmoCor blood pressure analysis system (SphygmoCor, Sydney, Australia). Aortic pulse wave form and central aortic pressures were derived by applanation tonometry of the radial artery. 15 The radial pressure waveform was recorded noninvasively with a micro manometer (Millar SPT 301; Millar Instruments, Houston, TX). The probe was held on the skin over the maximal arterial pulsation by hand and pressed down on the artery against the underlying bone. Ascending aortic pressure was derived from the central pressure waveform, using a generalized transfer function, which is incorporated in the SphygmoCor device. 16 PPA was calculated as a ratio (brachial PP/central PP).
To measure pulse wave velocity (PWV), participants were asked to lie down for 10 min before starting the procedure and to refrain from talking during the procedure. The SphygmoCor device allowed an online pulse wave recording and automatic calculation of PWV with two transducers (Millar SPT 301 pressure transducer; Millar Instruments, Houston, TX), one positioned at the base of the neck for the common carotid artery and the other over the femoral artery, as previously described. 17 The average of ten successive waveforms was used to cover a complete respiratory cycle. The whole procedure was repeated three times per subject, and the average value was used for the analysis. The intra-class correlation coefficient for repeated PWV-measurements was 85%.
Common CIMT was used to assess the extent of sub-clinical atherosclerosis. 13 Ultrasonography of both the left and right distal common carotid artery was performed using a 7.5-MHz linear array transducer (Acuson Aspen, Mountain View, CA) and a protocol that has been described in detail earlier. 18 The actual CIMT measurements were performed off-line. 19 In our laboratory, the intra-class correlation coefficient for repeated CIMT-measurement was 84%.
The Framingham risk score formula published by Anderson was used to calculate the 10-year risk of coronary heart disease. 20 Data analysis. Data on PPA were not available for 23 men. In addition, one extreme value of PPA ratio (0.79) was excluded, leaving 376 men for analysis. The association between cardiovascular risk factors and PPA was examined using linear regression analysis. In these analyses, we adjusted for age, heart articles Pulse Pressure Amplification and Cardiovascular Disease rate, MAP and height, as these factors may confound the PPA associations. 1, [21] [22] [23] The independent contribution of each variable was also evaluated in a stepwise multivariable regression analysis (Pin = 0.05, Pout = 0.10), by including all variables that remained related to PPA with P < 0.10 after adjustment for age, heart rate, MAP and height. For each participant, we calculated the Framingham risk score and determined the association between the absolute 10-year risk of coronary heart disease and PPA using linear regression analysis. The associations are presented with the linear regression coefficient (β) and their corresponding 95% confidence intervals (95% CIs) for continuous outcome variables or as an odds ratio and their corresponding 95% CI for dichotomous outcome variables. Statistical analyses were performed using statistical package SPSS, version 12.0 for Windows (SPSS, Chicago, IL). A P value of <0.05 was regarded statistically significant. All P values reported are two-sided.
reSUltS
The general characteristics of the study population are presented in Table 1 . PPA was normally distributed and showed a mean (s.d.) value of 1.34 (0.15).
Determinants of PPa
Age was significantly inversely related to PPA, also after adjustment for heart rate, MAP, and height. Heart rate, MAP, and All variables are adjusted for age, heart rate, mean arterial pressure, and height. a Adjusted for heart rate, mean arterial pressure, and height. b Adjusted for age, heart rate, and mean arterial pressure. c Adjusted for age, mean arterial pressure, and height. d Adjusted for age, heart rate, and height. e Diabetics excluded from analysis. f Adjusted for age, heart rate and height.
articles Pulse Pressure Amplification and Cardiovascular Disease height were related to an increased PPA ( Table 2 ). In models in which adjustments were made for age, heart rate, MAP, and height, PPA was significantly inversely related to waist-to-hip ratio, body mass index, triglycerides, smoking, number of pack-years, and hypertension ( Table 2 ). The relation with diabetes mellitus was borderline significant (P = 0.05). Table 3 shows the results of a stepwise multivariate analysis, in which heart rate, age, MAP, and height, as well as all variables that remained related to PPA with P < 0.10 after adjustment for age, heart rate, MAP, and height were taken into account. In this multivariate analysis, age, height, heart rate, MAP, waist-to-hip ratio, and current smoking remained significantly related to PPA ( Table 3) . The model explained ≈46% of the variability in PPA observed in the study.
PPa and cardiovascular risk
In models in which adjustments were made for age, heart rate, MAP, and height, PPA was significantly and inversely related to aortic PWV and common CIMT ( Table 4) . Similar findings were found for prevalent symptomatic cardiovascular disease (odds ratio 0.64, 95% CI 0.42 to 0.98, P = 0.042, result not shown in the table).
The absolute 10-year risk of coronary heart disease (%) increased with decreasing PPA (B = −3.06%/s.d. increase in PPA, 95% CI −4.14 to −1.99). When adjusting for age, the association was attenuated (B = −1.05, 95% CI −1.90 to −0.20) but remained statistically significant (P < 0.05) ( Table 4) . The relation between the risk estimate and PPA was graded (Figure 1) .
DiScUSSion
In this population-based single-center study among middle-aged men, we found that increased PPA was related to a reduced vascular risk, as assessed by a favorable risk factor profile, a reduced aortic PWV, a reduced common CIMT, and by a reduced estimated 10-year risk of coronary artery disease. Our findings are in line with the phenomenon that PPA attenuation can facilitate the forward transmission of potentially deleterious pressure pulsations into the microcirculation of vasodilated organs as the brain and heart, 2 which potentially portend an adverse clinical outcome, 2 as exemplified in a longitudinal study in subjects with end-stage renal disease, where a worse outcome for CV mortality with the attenuation of PPA was reported. 24 We expand the evidence by showing that a reduced PPA relates to established markers of cardiovascular risk, such as aortic PWV and common CIMT. These markers have been shown to strongly predict the occurrence of future events in observational studies. 25, 26 The importance of our findings lies herein that these relationships with markers of risk are independent of age, supporting the concept that vascular aging in some subjects occurs more rapidly than in others. The increased estimated risk of coronary heart disease using the Framingham risk score in middle-aged men with a reduced PPA is novel and further supports that notion. Furthermore, it confirms a report in treated hypertensive patients, in which PPA was related to the Framingham coronary CV risk estimation. 27 In these subjects, PPA was increased due to increased heart rate and alterations in arterial stiffness and pressure wave reflections.
Our findings are in agreement with results from other studies indicating that PPA reduces with age. 1 Also, relations between PPA and smoking, heart rate, and height have been reported earlier. For some earlier risk factors, such as hypercholesterolemia, physical activity and diabetes mellitus, we did not find significant relationships. This may be due to the precision with which some are being measured (physical activity) or due to the small number of subjects in our study population.
A limitation of our study is the cross-sectional design, which hampers the assessment of cause and effect. Although it is not conceivable that risk factors, other than blood pressure components, are a consequence of reduced PPA, an increased PWV and common CIMT might.
In summary, our study shows that increased PPA relates to a lower vascular risk, as assessed by a better cardiovascular risk profile, a lower PWV, common CIMT, and a lower estimated absolute risk of coronary heart disease.
